SPP1 and esophageal squamous cell carcinoma: Consistently, autoantibody to SPP1 in validation group could obviously discriminate patients with ESCC from NC since the AUC was 0.739 (95%CI: 0.671–0.871) with the sensitivity of 41.00% and the specificity of 87.00% (Fig. 4D, Table 4).